1. Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling. Issue 1 (December 2017) Authors: Berwick, Daniel; Javaheri, Behzad; Wetzel, Andrea; Hopkinson, Mark; Nixon-Abell, Jonathon; Grannò, Simone; Pitsillides, Andrew; Harvey, Kirsten Journal: Molecular neurodegeneration Issue: Volume 12:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Proteomic analysis reveals co-ordinated alterations in protein synthesis and degradation pathways in LRRK2 knockout mice. (18th June 2018) Authors: Pellegrini, Laura; Hauser, David N; Li, Yan; Mamais, Adamantios; Beilina, Alexandra; Kumaran, Ravindran; Wetzel, Andrea; Nixon-Abell, Jonathon; Heaton, George; Rudenko, Iakov; Alkaslasi, Mor; Ivanina, Natalie; Melrose, Heather L; Cookson, Mark R; Harvey, Kirsten Journal: Human molecular genetics Issue: Volume 27:Number 18(2018:Sep. 15) Page Start: 3257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗